← Back to Patent Explorer
US4284647A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for waste nitrogen removal

Assignee: Johns Hopkins University
•
Filing: 1980-03-31
•
Granted: 1981-08-18
•
Expires: 2000-03-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for controlling waste nitrogen accumulation diseases in humans which comprises administering an effective amount of at least one compound selected from the group consisting of benzoic acid, phenylacetic acid and the non-toxic, pharmaceutically-acceptable salts of the acids to a human suffering from waste nitrogen accumulation.

Inventors

  • 👤 Saul W. Brusilow
  • 👤 Mark L. Batshaw
  • 👤 Norman S. Radin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 20:38
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 100 words
A process for controlling waste nitrogen accumulation diseases in humans, caused by an impairment in the normal synthesis of urea from ordinary waste nitrogen in the body or in the normal excretion thereof, said process comprising administering an effective amount of at least one compound selected from the group consisting of benzoic acid, phenylacetic acid and the non-toxic, pharmaceutically-acceptable salts of said acids to a human suffering from such waste nitrogen accumulation disease, the amount of said compound used being sufficient to react with the waste nitrogen to form an amino acid acylation product for urinary discharge of said product.
Claim 2
Dependent Claim 100 words
A process for controlling waste nitrogen accumulation diseases in humans, caused by an impairment in the normal synthesis of urea from ordinary waste nitrogen in the body or in the normal excretion thereof, said process comprising administering an effective amount of at least one compound selected from the group consisting of benzoic acid, phenylacetic acid and the non-toxic, pharmaceutically-acceptable salts of said acids to a human suffering from such waste nitrogen accumulation disease, the amount of said compound used being sufficient to react with the waste nitrogen to form an amino acid acylation product for urinary discharge of said product.
Claim 3
Dependent Claim 19 words
The process of claim 1 wherein a mixture of benzoic acid and phenylacetic acid, or salts thereof, is administered.
Claim 4
Dependent Claim 20 words
The process of claim 1 wherein the administration is continued until the accumulated waste nitrogen is discharged as urinary nitrogen.
Claim 5
Dependent Claim 14 words
The process of claim 1 wherein the human is one with a urea-cycle enzymopathy.
Claim 6
Dependent Claim 13 words
The process of claim 1 wherein the human is one suffering from uremia.
Claim 7
Dependent Claim 15 words
The process of claim 1 wherein the human is one suffering from a hepatic disorder.
Claim 8
Dependent Claim 14 words
The process of claim 1 wherein the human is one suffering from Reye's syndrome.
Claim 9
Dependent Claim 33 words
The process of claim 1 wherein the administration of the benzoic acid or phenylacetic acid, or salts thereof, synthesizes hippuric acid and phenylacetylglutamine, respectively, and the synthesized product is discharged as urinary nitrogen.
Claim 10
Dependent Claim 11 words
The process of claim 1 wherein the salt is sodium salt.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-08-17 1985-02-16 1985-08-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-08-17 1989-02-16 1989-08-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-08-17 1993-02-16 1993-08-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag